Abstract
Background: Sartans are mostly used as a part of combination with additional medicines in the therapy of essencial hypertension. Preferred combinations are ARB and thiazide diuretics (Hydrochlorothiazide (HCT) and Chlorthalidone (CHL)) or ARB and calcium antagonists. The number of sartans mostly prescribed by specialists is only seven - Candesartan (CDS), Eprosartan (EPS), Irbesartan (IBS), Losartan (LOS), Olmesartan (OMS), Telmisartan (TMS) and Valsartan (VLS).
Methods: The widespread use of sartans in the treatment of hypertension requires reliable methods of analysis. Bulk drugs and pharmaceutical preparations should be analyzed to ensure the quality of the medicinal products reaching patients. On the other hand, the analysis of drugs in biological fluids aims to trace and improve patient care by adjusting the therapeutic doses of drugs. According to our knowledge, a review devoted to the analysis of sartans was published in 2014.
Results: Spectral methods are widely used in the analysis of bulk drugs and pharmaceutical dosage forms due to their relatively simple procedures, low reagent and sample consumption, speed, precision and accuracy combined with accessibility and comparatively low cost of common apparatus. Many papers for determination of sartans in bulk drugs and pharmaceutical preparations based on liquid chromatographic techniques were published in the available literature. Among these methods, HPLC takes the leading place but UPLC and HPTLC are also present.
Conclusion: The widespread use of sartans in the treatment of hypertension requires reliable methods of analysis. Bulk drugs and pharmaceutical preparations should be analyzed to ensure the quality of the medicinal products reaching patients. On the other hand, the analysis of drugs in biological fluids aims to trace and improve patient care by adjusting the therapeutic doses of drugs. Since 2014, many articles have been published on the sartans analysis and this provoked our interest to summarize the latest applications in the analysis of sartans in pharmaceutical formulations and biological media. Articles published from 2014 to 2018 are covered.
Keywords: Biological fluids, chromatography, drug analysis, HPLC, hypertension, sartans.
Graphical Abstract
[1]
Mancia, G.; Fagard, R.; Narkiewicz, K.; Redón, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; De Backer, G.; Dominiczak, A.; Galderisi, M.; Grobbee, D.E.; Jaarsma, T.; Kirchhof, P.; Kjeldsen, S.E.; Laurent, S.; Manolis, A.J.; Nilsson, P.M.; Ruilope, L.M.; Schmieder, R.E.; Sirnes, P.A.; Sleight, P.; Viigimaa, M.; Waeber, B.; Zannad, F. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens., 2013, 31(7), 1281-1357.
[http://dx.doi.org/10.1097/01.hjh.0000431740.32696.cc] [PMID: 23817082]
[http://dx.doi.org/10.1097/01.hjh.0000431740.32696.cc] [PMID: 23817082]
[2]
Ferreirós, N.; Iriarte, G.; Alonso, R.M.; Jiménez, R.M. Development of a solid phase extraction procedure for HPLC-DAD determination of several angiotensin II receptor antagonists in human urine using mixture design. Talanta, 2007, 73(4), 748-756.
[http://dx.doi.org/10.1016/j.talanta.2007.04.062] [PMID: 19073097]
[http://dx.doi.org/10.1016/j.talanta.2007.04.062] [PMID: 19073097]
[3]
Muszalska, I.; Sobczak, A.; Dołhań, A.; Jelińska, A. Analysis of Sartans: a review. J. Pharm. Sci., 2014, 103(1), 2-28.
[http://dx.doi.org/10.1002/jps.23760] [PMID: 24227012]
[http://dx.doi.org/10.1002/jps.23760] [PMID: 24227012]
[4]
Rewar, S.; Bansal, B.K.; Singh, C.J.; Sharma, A.K. approach for quantitative estimation of eprosartan mesylate by UV spectrophotometer. Int. J. Res. Dev. Pharm. L. Sci., 2014, 3(6), 1300-1303.
[5]
Ghule, A.R.; Shinkar, D.M.; Saudagar, R.B. UV Spectrometric method for the estimation of eprosartan mesylate in bulk and pharmaceutical formulation. Int. J. Pharm. Sci. Res., 2015, 6(1), 70-73.
[6]
Bhupendra, P.D.; Manohar, S.D.; Bhanudas, S.R.; Kailas, B.J. UV Spectrophotometric method for estimation of eprosartan mesylate in bulk and in pharmaceutical formulation. Asian J. Pharm. Anal., 2016, 6(2), 119-121.
[http://dx.doi.org/10.5958/2231-5675.2016.00018.1]
[http://dx.doi.org/10.5958/2231-5675.2016.00018.1]
[7]
Naveed, S. Analytical method for estimation of losartan by using UV Spectrophotometer. Global J. Med. Res. (B), 2014, 14(4), 14-18.
[8]
Ashraf, Z.; Waheed, N.; Naz, E.; Ahmed, F.; Asim, T.; Muzammil, F.; Saghira, S.; Ayub, M. Assay for quantitative analysis of losartan
potassium by using UV Spectroscopy. Global J. Med. Res.: (B),, 2015, 15(4), 35-37.
[9]
Gawai, M.N.; Aher, S.S.; Saudager, R.B.; New, U.V. Spectrophotometric method development and validation of valsartan in bulk and pharmaceutical dosage forms. Asian J. Res. Chem, 2016, 9(9), 441-444.
[http://dx.doi.org/10.5958/0974-4150.2016.00066.3]
[http://dx.doi.org/10.5958/0974-4150.2016.00066.3]
[10]
Raul, S.K.; Padhy, G.K.; Krishna, P.R.; Priya, B.U.M. UV spectrophotometric method development and validation for the estimation of valsartan in bulk and pharmaceutical dosage form. Asian J. Pharm. Anal., 2016, 6(3), 147-150.
[http://dx.doi.org/10.5958/2231-5675.2016.00023.5]
[http://dx.doi.org/10.5958/2231-5675.2016.00023.5]
[11]
Kalyani, G.; Adjuad, B. Stability indicating assay and estimation of irbesartan by first Order UV Derivative Spectrophotometry. Int. J. Pharm. Sci. Res., 2017, 8(9), 3817-3821.
[12]
Mukthinuthalapati, M.A.; Phani Kumar, J.S.P. Simultaneous derivative spectrophotometric determination of candesartan cilexetil and hydrochlorothiazide. Pharm. Methods, 2015, 6(3), 148-151.
[13]
Merey, H.A.; Ramadan, N.K.; Diab, S.S.; Moustafa, A.A. Spectrophotometric methods for simultaneous determination of ternary mixture of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2014, 125, 138-146.
[http://dx.doi.org/10.1016/j.saa.2014.01.095] [PMID: 24534425]
[http://dx.doi.org/10.1016/j.saa.2014.01.095] [PMID: 24534425]
[14]
Solanki, B.K.; Dave, J.B.; Raval, P.P. Development and validation of UV spectrophotometric methods for simultaneous estimation of rosuvastatin and Telmisartan in tablet dosage form. World J. Pharm. Pharm. Sci., 2014, 3(6), 2030-2041.
[15]
Stolarczyk, M.; Apola, A.; Maślanka, A.; Kwiecień, A.; Opoka, W. Spectrophotometric method for simultaneous determination of valsartan and substances from the group of statins in binary mixtures. Acta Pharm., 2017, 67(4), 463-478.
[http://dx.doi.org/10.1515/acph-2017-0031] [PMID: 29337671]
[http://dx.doi.org/10.1515/acph-2017-0031] [PMID: 29337671]
[16]
Lotfy, H.M.; Hegazy, M.A.; Mowaka, S.; Mohamed, E.H. Novel spectrophotometric methods for simultaneous determination of Amlodipine, Valsartan and Hydrochlorothiazide in their ternary mixture. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2015, 140, 495-508.
[http://dx.doi.org/10.1016/j.saa.2014.12.096] [PMID: 25638433]
[http://dx.doi.org/10.1016/j.saa.2014.12.096] [PMID: 25638433]
[17]
Abdelmonem, A.A.; Ragab, G.H.; Hashem, H.A.; Bahgad, E.A. Spectrofluorimetric and spectrophotometric determination of irbesartan and bisoprolol hemifumarate independently in their tablets. UK J. Pharm. Biosci., 2016, 4(2), 43-52.
[http://dx.doi.org/10.20510/ukjpb/4/i2/97093]
[http://dx.doi.org/10.20510/ukjpb/4/i2/97093]
[18]
Amin, A.S.; Salah, H.M.; Ragab, G.H.; Kamel, I.S. Sensitive spectrophotometric and conductometric methods for determination of candesartan using bromocresol green and bromocresol purple by ion-pair complex formation. J. Chem. Mat. Res., 2015, 2(2), 42-48.
[19]
Abou-elkheir, A.; Saleh, H.M.; El-henawee, M.M.; Ghareeb, B.E.S. Spectrophotometric determination of terbinafine HCl and telmisartan using potassium permanganate. Int. J. Pharm. Chem. Biol. Sci., 2015, 5(1), 361-371.
[20]
Demirkaya-Miloglu, F.; Yaman, M.E.; Kadioglu, Y. Optimization of a spectrofluorimetric method based on a central composite design for the determination of potassium losartan in pharmaceutical products. Braz. J. Pharm. Sci., 2014, 50(3), 611-619.
[http://dx.doi.org/10.1590/S1984-82502014000300021]
[http://dx.doi.org/10.1590/S1984-82502014000300021]
[21]
Rahul, R.; Narayanaswamy, V.B. Development of RP-HPLC method for the simultaneous estimation of candesartan cilexetil and hydrochlorothiazide in pharmaceutical dosage Forms. Int. J. Res. Pharm. Chem., 2015, 5(3), 452-469.
[22]
Sujana, K.; Vimmy Hamuthal, M.Z. New Validated RP-HPLC method for the determination of eprosartan in bulk and pharmaceutical dosage form. World J. Pharm. Pharm. Sci., 2014, 3(12), 1403-1410.
[23]
Rewar, S.; Sharma, A.K.; Bansal, B.K.; Singh, C.J. RP-HPLC method for the simultaneous determination of eprosartan mesylate in pharmaceutical preparations. Int. J. Res. Dev. Pharm. L. Sci., 2015, 4(3), 1559-1568.
[24]
Ahad, A.; Mohammed Al-Mohizea, A.; Abdullah Al-Saleh, A.; Sulaman Alwabel, A.; Jaber Aqel, A.; Mahdi Al-Qahtani, K.; Al-Jenoobi, F.I. Validation of a rapid and sensitive hplc-uv method for the quantification of eprosartan mesylate in bulk drug, tevententm and ultradeformable lipid based vesicular system. Curr. Pharm. Anal., 2016, 12(3), 208-213.
[http://dx.doi.org/10.2174/1573412911666150917195649]
[http://dx.doi.org/10.2174/1573412911666150917195649]
[25]
Dangre, P.; Sawale, V.; Meshram, S.; Gunde, M. Development and validation of RP-HPLC method for the simultaneous estimation of eprosartan mesylate and chlorthalidone in Tablet dosage form. Int. J. Pharm. Tech. Res., 2015, 8(2), 163-168.
[26]
Gumulapuram, S.; Thota, S.; Kumar, V.R.; Nagabandi, V.K. Stability Indicating RP-HPLC method development and validation for the simultaneous estimation of eprosartan Mesylate and hydrochlorothiazidein bulk and tablet dosage form. Int. J. Pharm. Pharm. Sci., 2014, 6(2), 446-451.
[27]
Srinivasu, T.; Annapurna, M.M. Development and validation of a new stability indicating RP-HPLC method for the determination of Eprosartan and Hydrochlorothiazide. J. Chem. Pharm. Sci., 2017, 10(2), 790-797.
[28]
Ingale, P.L.; Dalvi, S.D.; Salunkhe, A.R. Development and validation of HPLC Method for the estimation of irbesartan. Indo Americ. J. Pharm. Res., 2016, 6(4), 5242-5247.
[29]
Kalyankar, T.M.; Wadher, S.J.; Pekamwar, S.S.; Doiphode, N.G. Development and validation of RP- HPLC method for estimation of hydrochlorothiazide and irbesartan in pharmaceutical preparation. Int. J. Pharm. Tech. Res., 2014, 6(1), 330-336.
[30]
Alanazi, A.M.; Abdelhameed, A.S.; Khalil, N.Y.; Khan, A.A.; Darwish, I.A. HPLC method with monolithic column for simultaneous determination of irbesartan and hydrochlorothiazide in tablets. Acta Pharm., 2014, 64(2), 187-198.
[http://dx.doi.org/10.2478/acph-2014-0014] [PMID: 24914719]
[http://dx.doi.org/10.2478/acph-2014-0014] [PMID: 24914719]
[31]
Awad Ali, T.; Mohamed, G.G.; Aglan, A.A.; El-Taib Heakal, F. RP-HPLC Stability-indicating method for estimation of irbesartan and hydrochlorothiazide in bulk and pharmaceutical dosage Form. Chin. J. Anal. Chem., 2016, 44(1), 1601-1608.
[http://dx.doi.org/10.1016/S1872-2040(16)60899-X]
[http://dx.doi.org/10.1016/S1872-2040(16)60899-X]
[32]
Aneesh, T.P.; Radhakrishnan, R.; Aravind, P.M.; Sasidharan, A.; Choyal, M. RP-HPLC method for simultaneous determination of losartan and chlorthalidone in pharmaceutical dosage form. Int. Res. J. Pharm., 2015, 6(7), 453-457.
[http://dx.doi.org/10.7897/2230-8407.06793]
[http://dx.doi.org/10.7897/2230-8407.06793]
[33]
Topalli, S.; Mukthinuthalapati, M.A. A New Stability Indicating RP-HPLC method for the analysis of losartan and hydrochlorothiazide tablets. J. Chem. Pharm. Sci., 2017, 10(2), 798-802.
[34]
Shakya, A.K. HPLC-PDA Determination of losartan potassium and hydrochlorothiazide using design of experiments. Jordan J. Pharm. Sci., 2015, 8(3), 153-171.
[http://dx.doi.org/10.12816/0030448]
[http://dx.doi.org/10.12816/0030448]
[35]
Vijayalakshmi, R.; Sandya, P.; Poorna Chandra Rao, M.; Dhanaraju, M.D. RP-HPLC method for the simultaneous estimation of perindopril and losartan in pure form and Tablet Formulations. Int. J. Pharm. Sci. Drug Res., 2014, 6(1), 75-77.
[36]
Venketeswara Rao, B.; Vidyadhara, S.; Sasidhar, R.L.C.; Ganesh Kumar, T.N.V.; Rokiya, Md. A Novel Stability Indicating RP-HPLC method development and validation for the simultaneous estimation of losartan potassium, ramipril and hydrochlorothiazide in Bulk and Pharmaceutical Dosage Form. Eurasian J. Anal. Chem., 2016, 11(5), 255-265.
[37]
Sawale, V.; Dangre, P.; Dhabarde, D. Development and validation of RP-HPLC method for the simulteneous estimation of olmesartan medoxomil and chlorthalidone in tablet Dosage Form. Int. J. Pharm. Pharm. Sci., 2015, 7(5), 266-269.
[38]
Manikandan, S.; Thirunarayanan, G. Development and validation of reversed phase gradient HPLC method for the simultaneous estimation of olmesartan medoxomil and chlorthalidone in dosage forms. World Sci. News, 2015, 9, 132-154.
[39]
Gayathri, S.; Sireesha, D.; Akiful Haque, M.; Harshini, S.; Bhakshi, V.; Reddy, S.K. Method development and validation of rp-hplc method for simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide in bulk and pharmaceutical dosage Form. Int. J. Pharma Res. Health Sci., 2014, 2(6), 457-462.
[40]
Rudrapal, M.; Oduri, M.U.; Rao Samidala, N.; Surya Kiran, B.V.V.S.; Ali Junejo, J.; Singh, K.D.; Chakraborty, T.; Debnath, M. Development and validation of RP HPLC method for simultaneous estimation of olmesartan and hydrochlorothiazide in tablet Dosage Form. Orient. J. Chem., 2015, 31(2), 921-926.
[http://dx.doi.org/10.13005/ojc/310236]
[http://dx.doi.org/10.13005/ojc/310236]
[41]
Vidyadhara, S.; Sasidhar, R.L.; Venkateswara Rao, B.; Tejaswi, K.; Reshma, M. Method development and validation for simultaneous estimation of olmesartan medoxomil and Hydrochlorothiazide by RP-HPLC. Orient. J. Chem., 2014, 30(1), 195-201.
[http://dx.doi.org/10.13005/ojc/300123]
[http://dx.doi.org/10.13005/ojc/300123]
[42]
Ashok Kumar, J. Simultaneous Estimation of olmesartan medoxomil and hydrochlorothiazide by RP-HPLC method from combined dosage forms. Int. J. Res. Pharm. Sci., 2016, 1(1), 24-27.
[43]
Ashutosh Kumar, S.; Debnath, M. Seshagiri Rao, J.V.L.N.; Gowri Sankar, D. A new and rapid analytical method development & validation for simultaneous estimation of hydrochlorothiazide, amlodipine & olmesartan in tablet dosage form by using RP-HPLC. J. Chem. Pharm. Res., 2014, 6(5), 1208-1213.
[44]
Sharma, T.; Sudam, C.; Si Sankar, D.G. Development and validation of LC Method for the simultaneous estimation of rosuvastatin calcium and olmesartan medoxomil in pharmaceutical dosage form. Int. J. Chemtech Res., 2014, 6(2), 1115-1123.
[45]
Shaina, S.; Varinder, S.; Sandeep, R.; Nitish, B. Development and validation of method for the estimation of telmisartan as active pharmaceutical ingredient in tablet dosage form and prepared spherical agglomerates by RP-HPLC. J. Pharm. Technol. Res. Manag, 2016, 4(1), 63-79.
[http://dx.doi.org/10.15415/jptrm.2016.41005]
[http://dx.doi.org/10.15415/jptrm.2016.41005]
[46]
Patel, B.A.; Captain, A.D. RP-HPLC Method for simultaneous estimation of telmisartan and hydrochlorothiazide in API and dosage form. Indo American J. Pharm. Res., 2014, 4(6), 3031-3038.
[47]
Duza, M.B.; Kumar, S.A.; Kumar, G.V.; Saka, V.P.; Malik, N. Method development and validation for simultaneous estimation of hydrochlorothiazide and telmisartan in Bi-layered tablet dosage form by RP-HPLC. Indo American J. Pharm. Res., 2015, 5(1), 303-325.
[48]
Sasidhar, R.L.C.; Vidyadhara, S.; Deepti, B.; Tejaswi, K.; Suhasini, J. Development and validation of RP - HPLC Method for the Simultaneous Determination of hydrochlorothiazide, amlodipine besylate and telmisartan in bulk and pharmaceutical formulation. Orient. J. Chem., 2014, 30(4), 1815-1822.
[http://dx.doi.org/10.13005/ojc/300442]
[http://dx.doi.org/10.13005/ojc/300442]
[49]
Rathnam, R.P.; Sravanthi, S. Estimation and validation of a polypill containing Amlodipine Besylate, Hydrochlorothiazide and Telmisartan by RP-HPLC. American J. Drug Deliv. Therap., 2015, 2(4), 92-105.
[50]
Kumar, L.; Sreenivasa Reddy, M.; Managuli, R.S.; Pai K, G. Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles. Saudi Pharm. J., 2015, 23(5), 549-555.
[http://dx.doi.org/10.1016/j.jsps.2015.02.001] [PMID: 26594122]
[http://dx.doi.org/10.1016/j.jsps.2015.02.001] [PMID: 26594122]
[51]
Maslarska, V.; Peikova, L.; Tsvetkova, B. Method Development and validation of Valsartan and Hydrochlorothiazide in pharmaceutical dosage form. Int. J. Pharma Bio Sci., 2014, 5(1), 205-211.
[52]
Udaykumar Rao, B.; Nikalje, A.P. Simultaneous determination of valsartan and Hydrochlorothiazide in a tablet dosage form by liquid chromatography. Afr. J. Pharm. Pharmacol., 2014, 8(38), 953-961.
[53]
Shakya, A.K. Development and validation of a stability-indicating liquid chromatographic method for determination of valsartan and hydrochlorthiazide using quality by design. Orient. J. Chem., 2016, 32(2), 777-788.
[http://dx.doi.org/10.13005/ojc/320203]
[http://dx.doi.org/10.13005/ojc/320203]
[54]
Nekkala, K.; Shanmukha Kumar, J.V.; Ramachandran, D.; Ramanaiah, G.; Srinivas, G. Method Development and Validation of stability indicating RP-HPLC method for simultaneous estimation of nebivolol HCL and valsartan in bulk and its pharmaceutical formulations. American J. Adv. Drug Deliv., 2014, 2(5), 624-637.
[55]
Rajoriya, V.; Kashaw, V. RP-HPLC method for the simultaneous estimation of nebivolol hydrochloride and valsartan. Anal. Chem. Lett., 2017, 7(4), 520-530.
[http://dx.doi.org/10.1080/22297928.2017.1362994]
[http://dx.doi.org/10.1080/22297928.2017.1362994]
[56]
Patel, K.H.; Luhar, S.V.; Narkhede, S.B. Simultaneous estimation of sacubitril and valsartan in synthetic mixture by RP-HPLC Method. J. Pharm. Sci. Bioscientific Res., 2016, 6(3), 262-269.
[57]
Bkhaitan, M.M.; Mirza, A.Z. Stability-indicating HPLC-DAD method for simultaneous determination of atorvastatin, irbesartan, and amlodipine in bulk and pharmaceutical preparations. Bull. Korean Chem. Soc., 2015, 36(9), 2230-2237.
[http://dx.doi.org/10.1002/bkcs.10433]
[http://dx.doi.org/10.1002/bkcs.10433]
[58]
Paras, V.; Sojitra, R.; Savaj, B.; Hashumati, R.; Jain, V.; Patel, K. Development and validation of RP-HPLC method for the simultaneous estimation of Irbesartan and Atorvastatin in synthetic mixture. J. Sci. Technol., 2015, 1(1), 13-22.
[http://dx.doi.org/10.5958/2231-5713.2015.00025.2]
[http://dx.doi.org/10.5958/2231-5713.2015.00025.2]
[59]
Hashem, H.; Ehab, A.; Elhenawee, M. Simultaneous determination of the antihypertensives hydrochlorothiazide, losartan potassium, irbesartan and valsartan in bulk powders and pharmaceutical preparations by high performance liquid Chromatography. Main Group Chem., 2016, 15(4), 335-346.
[http://dx.doi.org/10.3233/MGC-160213]
[http://dx.doi.org/10.3233/MGC-160213]
[60]
Tahir, M.S.; Adnan, A.; Syed, Q. Chromatographic resolution of angiotensin II receptor antagonists (sartans). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2016, 1027, 57-63.
[http://dx.doi.org/10.1016/j.jchromb.2016.05.023] [PMID: 27258943]
[http://dx.doi.org/10.1016/j.jchromb.2016.05.023] [PMID: 27258943]
[61]
Ravisankar, P.; Vineela, C.; Koushik, O.S.; Srinivasa Babu, P. Novel simultaneous separation and quantitative determination of
telmisartan, losartan, olmesartan and irbesartan in presence of hydrochlorothiazide
by isocratic RP-HPLC. Adv J Pharm Life sci Res., 2015, 3(4), 1-18.
[62]
Ravisankar, P.; Manjusha, K.; Sri, V.L.; Kumar, B.V.; Rajyalakshmi, K.; Srinivasa Babu, P. Quantitative estimation of four sartans in presence of hydrochlorothiazide in pharmaceutical preparations by high performance liquid chromatography. Br. J. Pharm. Res., 2016, 11(4), 1-15.
[http://dx.doi.org/10.9734/BJPR/2016/25354]
[http://dx.doi.org/10.9734/BJPR/2016/25354]
[63]
Ravisankar, P.; Devi, M.S.; Ravali, B.; Tejaswini, K.; Balaji, D.; Lakshmi, N.S.; Ravi Teja, R.V. SrinivasaBabu, P. Rapid Simultaneous separation of four sartans by isocratic RP-HPLC Method: Application to determination of olmisartan in pharmaceutical dosage form. J. Chem. Pharm. Sci., 2015, 8(1), 61-71.
[64]
Maslarska, V.; Yankov, V.; Obreshkova, D.; Bozhanov, S. Simultaneous determination of sartans by high performance liquid chromatography with ultra violet detection. Indian J. Pharm. Edu. Res., 2017, 51(2), 343-348.
[http://dx.doi.org/10.5530/ijper.51.2.41]
[http://dx.doi.org/10.5530/ijper.51.2.41]
[65]
Pawar, H.A.; Lalitha, K.G. Development and validation of a novel
rp-hplc method forestimation of losartan potassium in dissolution
samples of immediate and sustained release tablets. Chrom. Res.
Int.,, 2014.
[66]
Dutta, K.K.; Al-Othman, Z.A.; Mandal, G.; Ali, I. New antihypertensive tablets formulation and hplc analyses using new generation core shell column. American J. Adv. Drug Deliv., 2014, 2(4), 534-556.
[67]
Gričar, M.; Andrenšek, S. Determination of azide impurity in sartans using reversed-phase HPLC with UV detection. J. Pharm. Biomed. Anal., 2016, 125, 27-32.
[http://dx.doi.org/10.1016/j.jpba.2016.03.020] [PMID: 26999319]
[http://dx.doi.org/10.1016/j.jpba.2016.03.020] [PMID: 26999319]
[68]
Prabhu, P.; Muralidhar, M. Development & validation of a high performance liquid chromatography method for simultaneous determination of irbesartan and its related impurities in pharmaceutical tablets. Int. J. Pharm. Sci. Drug Res., 2014, 6(2), 145-153.
[69]
Qiu, S.; Liu, K.; Ma, P.; Wang, M.; Chen, H.; Xu, X.; Hao, X.; Wang, Y. Simultaneous analysis of losartan potassium and its related impurities and degradation products in tablets using HPLC. Curr. Pharm. Anal., 2015, 11, 25-34.
[http://dx.doi.org/10.2174/1573412910999141010152758]
[http://dx.doi.org/10.2174/1573412910999141010152758]
[70]
Ibrahim, M.M.; Hegazy, M.A.; El-Ghani, M.A. Application of a RP-HPLC method for comparative study on the degradation behavior of two angiotensin II Receptor Antagonists, Valsartan and Losartan Potassium. Int. J. Pharm. Chem. Biol. Sci., 2015, 5(2), 417-426.
[71]
Golubović, J.B.; Protić, A.D.; Zečević, M.L.; Otašević, B.M. Quantitative Structure retention relationship modeling in liquid chromatography method for separation of Candesartan Cilexetil and its Degradation Products. Chemom. Intell. Lab. Syst., 2015, 140, 92-101.
[http://dx.doi.org/10.1016/j.chemolab.2014.11.005]
[http://dx.doi.org/10.1016/j.chemolab.2014.11.005]
[72]
Ganthi, H.K.R.; Reddy, P.R.; Park, Y.J.; Park, S.J.; Cho, W.H. Stability Indicating RP-HPLC method for quantification of impurities in valsartan and hydrochlorothiazide FDC Tablet Dosage Form. Am. J. Anal. Chem., 2016, 7, 816-839.
[http://dx.doi.org/10.4236/ajac.2016.711072]
[http://dx.doi.org/10.4236/ajac.2016.711072]
[73]
Taleuzzaman, M.; Ali, S.; Gilani, S.J.; Imam, S.S.; Hafeez, A. Ultra Performance Liquid Chromatography (UPLC) - A Review. Austin J. Anal. Pharm. Chem., 2015, 2(6), 1056-1060.
[74]
Lahsini, R.; Monser, L. Development of a New UPLC Method for Simultaneous determination of valsartan, amlodipine besylate, and hydrochlorothiazide Pharmaceutical Products. Acta Chrom., 2015, 27(3), 449-460.
[http://dx.doi.org/10.1556/AChrom.27.2015.3.4]
[http://dx.doi.org/10.1556/AChrom.27.2015.3.4]
[75]
Vojta, J.; Jedlička, A.; Coufal, P.; Janečková, L. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form. J. Pharm. Biomed. Anal., 2015, 109, 36-44.
[http://dx.doi.org/10.1016/j.jpba.2015.01.059] [PMID: 25756663]
[http://dx.doi.org/10.1016/j.jpba.2015.01.059] [PMID: 25756663]
[76]
Hamid, K.; Mushir, A.; Alka, A.; Javed, A. Application of Validated UPLC/Q-TOF-MS method for simultaneous determination of telmisartan, hydrochlorothiazide and their Degradation Products in Tablets. Asian J. Res. Pharm. Sci., 2017, 7(2), 105-111.
[http://dx.doi.org/10.5958/2231-5659.2017.00016.9]
[http://dx.doi.org/10.5958/2231-5659.2017.00016.9]
[77]
Tengli, A.R.; Shivakumar, G.; Gurupadayya, B.M. UPLCMS Method Development and validation of amlodipine, hydrochlorthiazide and losartan in combined tablet Dosage Form. Am. J. Anal. Chem., 2015, 6(3), 228-238.
[http://dx.doi.org/10.4236/ajac.2015.63021]
[http://dx.doi.org/10.4236/ajac.2015.63021]
[78]
Reddy, R.S.; Krishna, R.M.; Vekaria, N.A.; Rao, S.V.; Mantena, B.P.V. Method development and validation for the determination of potential impurities present in olmesartan medoxomil and hydrochlorothiazide in fixed dose combination drug product by using reverse phase - ultra-performance liquid chromatography coupled with Diode-Array Detector. J. Liquid Chrom. Rel. Tech., 2015, 38(13), 1343-1354.
[http://dx.doi.org/10.1080/10826076.2015.1048877]
[http://dx.doi.org/10.1080/10826076.2015.1048877]
[79]
Attimarad, M.; Ahmed, K.K.M.; Aldhubaib, B.E.; Harsha, S. High-performance thin layer chromatography: A powerful analytical technique in pharmaceutical drug discovery. Pharm. Methods, 2011, 2(2), 71-75.
[http://dx.doi.org/10.4103/2229-4708.84436] [PMID: 23781433]
[http://dx.doi.org/10.4103/2229-4708.84436] [PMID: 23781433]
[80]
Khanvilkar, V.; Dalvi, V.; Tambe, A.; Parmar, D.; Kadam, V. Stability Indicating HPTLC method for determination of eprosartan mesylate from bulk drug and pharmaceutical Formulations. Indo American J. Pharm. Res., 2014, 4(1), 483-490.
[81]
Tambe, V.; Deodhar, M.; Prakya, V. Simultaneous quantitative
estimation of Telmisartan and Hy-drochlorothiazide in bulk and
marketed tablet formulation by HPTLC-a Stability indicating
method. Int. J. Pharm. Chem. Anal., 4(3), 88-96.
[82]
Marolia, B.P.; Bodiwala, K.B.; Shah, S.A.; Prajapati, P.B.; Satani, B.H.; Desai, S.A. Development and validation of HPTLC method for simultaneous estimation of amlodipine besylate, hydrochlorothiazide and telmisartan in their combined tablet Dosage Form. Pharm. Methods, 2016, 7(1), 48-53.
[http://dx.doi.org/10.5530/phm.2016.7.8]
[http://dx.doi.org/10.5530/phm.2016.7.8]
[83]
Jadhav, M.L.; Girase, M.V.; Tidme, S.K. Development and validation of HPTLC method for simultaneous estimation of Valsartan and Hydrochlorothiazide in tablet dosage form. J. Pharm. Biomed. Sci., 2015, 2, 20-25.
[84]
Solanki, T.B.; Shah, P.A.; Patel, K.G. Central composite design for validation of HPTLC method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in Tablets. Indian J. Pharm. Sci., 2014, 76(3), 179-187.
[PMID: 25035528]
[PMID: 25035528]
[85]
Whatley, H. Basic Principles and Modes of Capillary Electrophoresis. Clinical and Forensic Applications of Capillary Electrophoresis. Pathology and Laboratory Medicine; Petersen, J.R; Mohammad, A.A., Ed.; Humana Press: Totowa, NJ, 2001, pp. 21-58.
[86]
Attimarad, M.; Nagaraja, S.H.; Al-Dhubaib, B.E.; Nair, A.B.; Narayanaswamy, Y.K. Capillary Electrophoresis: MEKC assay method for simultaneous determination of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets. Indian J. Pharm. Edu. Res., 2016, 50(2), 188-195.
[87]
Adriana, M.; Gabriel, H.; Alexandru, V.R.; Stefana, S.; Ruxandra, S.; Hajnal, K. Simultaneous determination of amlodipine and telmisartan from pharmaceutical products by way of capillary electrophoresis. Curr. Issues Pharm. Med. Sci., 2016, 29(1), 42-45.
[http://dx.doi.org/10.1515/cipms-2016-0010]
[http://dx.doi.org/10.1515/cipms-2016-0010]
[88]
Ebeid, W.; Salim, M.; Elkady, E.; Elzahr, A.; El-Bagary, R.; Patonay, G. Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE). Pharmazie, 2015, 70(6), 368-373.
[PMID: 26189296]
[PMID: 26189296]
[89]
Stacescu, S.; Hancu, G.; Gagyi, L.; Soare, R.M.; Kelemen, H. Simultaneous determination of hydrochlorothiazide and telmisartan from pharmaceutical preparations using Capillary Electrophoresis. STUDIA UBB CHEMIA, LXII, 2. Tom, 2017, II, 189-198.
[90]
Lee, K.R.; Nguyen, N.T.; Lee, Y.J.; Choi, S.; Kang, J.S.; Mar, W.; Kim, K.H. Determination of the R-enantiomer of valsartan in pharmaceutical formulation by capillary electrophoresis. Arch. Pharm. Res., 2015, 38(5), 826-833.
[http://dx.doi.org/10.1007/s12272-014-0449-7] [PMID: 25052956]
[http://dx.doi.org/10.1007/s12272-014-0449-7] [PMID: 25052956]
[91]
Dangre, P.V.; Dhole, S.N. Development and Validation of RP-HPLC Method for determination of eprosartan mesylate in rat plasma: application to preclinical Pharmacokinetic Study. Pharm. Methods, 2015, 6(2), 100-104.
[http://dx.doi.org/10.5530/phm.2015.6.14]
[http://dx.doi.org/10.5530/phm.2015.6.14]
[92]
Zhang, H.; Jiang, Y.; Wen, J.; Zhou, T.; Fan, G.; Wu, Y. Rapid determination of telmisartan in human plasma by HPLC using a monolithic column with fluorescence detection and its application to a bioequivalence study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877(29), 3729-3733.
[http://dx.doi.org/10.1016/j.jchromb.2009.08.028] [PMID: 19744898]
[http://dx.doi.org/10.1016/j.jchromb.2009.08.028] [PMID: 19744898]
[93]
Forjan, V.; Cvitkovič Maričič, L.; Prosen, H.; Brodnjak Vončina, D. Determination of Candesartan in Human Plasma with Liquid Chromatography - Tandem Mass Spectrometry. Acta Chim. Slov., 2016, 63(1), 38-46.
[http://dx.doi.org/10.17344/acsi.2015.1836] [PMID: 26970787]
[http://dx.doi.org/10.17344/acsi.2015.1836] [PMID: 26970787]
[94]
Dubey, R.; Ghosh, M. Simultaneous Determination and pharmacokinetic study of losartan, losartan carboxylic acid, ramipril, ramiprilat, and hydrochlorothiazide in rat plasma by a liquid chromatography/tandem mass spectrometry method. Sci. Pharm., 2014, 83(1), 107-124.
[http://dx.doi.org/10.3797/scipharm.1410-15] [PMID: 26839805]
[http://dx.doi.org/10.3797/scipharm.1410-15] [PMID: 26839805]
[95]
George, M.; Joseph, L.; Jain, A.K.; Anju, V. Bioanalytical method development and validation of simultaneous analysis of telmisartan and hydrochlorthiazide in human plasma using LC-MS/MS. Int. J. Bioassays, 2016, 5(3), 4862-4869.
[http://dx.doi.org/10.21746/ijbio.2016.03.003]
[http://dx.doi.org/10.21746/ijbio.2016.03.003]
[96]
Jangala, H.; Vats, P.; Khuroo, A.H.; Monif, T. Development and validation of a LC-MS/MS method for the simultaneous estimation of amlodipine and valsartan in human Plasma: Application to a bioequivalence study. Sci. Pharm., 2014, 82(3), 585-600.
[http://dx.doi.org/10.3797/scipharm.1402-11] [PMID: 25853070]
[http://dx.doi.org/10.3797/scipharm.1402-11] [PMID: 25853070]
[97]
Wani, T.A.; Zargar, S. New ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of irbesartan in human plasma. Yao Wu Shi Pin Fen Xi, 2015, 23(3), 569-576.
[http://dx.doi.org/10.1016/j.jfda.2015.02.008] [PMID: 28911717]
[http://dx.doi.org/10.1016/j.jfda.2015.02.008] [PMID: 28911717]
[98]
Qiu, X.; Wang, Z.; Wang, B.; Zhan, H.; Pan, X.; Xu, R.A. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 957, 110-115.
[http://dx.doi.org/10.1016/j.jchromb.2014.03.002] [PMID: 24681823]
[http://dx.doi.org/10.1016/j.jchromb.2014.03.002] [PMID: 24681823]
[99]
Shah, P.A.; Sharma, P.; Shah, J.V.; Sanyal, M.; Shrivastav, P.S. Simultaneous analysis of losartan, its active metabolite, and hydrochlorothiazide in human plasma by a UPLC-MS/MS method. Turk. J. Chem., 2015, 39, 714-733.
[http://dx.doi.org/10.3906/kim-1502-4]
[http://dx.doi.org/10.3906/kim-1502-4]
[100]
Geetha, G.; Gnana Raja, M. High-sensitivity simultaneous liquid chromatography / tandem mass spectrometry (UPLC/MS/MS) assay of olmesartan medoxomil, hydrochlorothiazide and amlodipine besylate in human plasma. Int. J. Res. Pharm. Sci., 2018, 9(2), 284-297.
[101]
Wani, T.A.; Zargar, S. New Highly-Sensitive Ultra-Performance Liquid chromatography - mass spectrometry method for quantification of telmisartan in human Plasma. Trop. J. Pharm. Res., 2015, 14(3), 511-518.
[http://dx.doi.org/10.4314/tjpr.v14i3.21]
[http://dx.doi.org/10.4314/tjpr.v14i3.21]
[102]
Chen, X.; Xu, B.; Yang, J.; Liu, J.; Fang, D.; Gu, Y.; Jian, Z.; Tang, M.; Fu, C.; Zhang, Z.; Jiang, C.; Song, X. Simultaneous determination of telmisartan and pitavastatin in rat plasma by UPLC-MS/MS: Application to pharmacokinetic interaction study. J. Pharm. Biomed. Anal., 2016, 131, 373-379.
[http://dx.doi.org/10.1016/j.jpba.2016.09.006] [PMID: 27643859]
[http://dx.doi.org/10.1016/j.jpba.2016.09.006] [PMID: 27643859]
[103]
De Nicolò, A.; Avataneo, V.; Rabbia, F.; Bonifacio, G.; Cusato, J.; Tomasello, C.; Perlo, E.; Mulatero, P.; Veglio, F.; Di Perri, G.; D’Avolio, A. UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients. J. Pharm. Biomed. Anal., 2016, 129, 535-541.
[http://dx.doi.org/10.1016/j.jpba.2016.07.049] [PMID: 27497654]
[http://dx.doi.org/10.1016/j.jpba.2016.07.049] [PMID: 27497654]
[104]
De Nicolò, A.; Avataneo, V.; Rabbia, F.; Sciandra, M.; Tosello, F.; Cusato, J.; Perlo, E.; Mulatero, P.; Veglio, F.; Di Perri, G.; D’Avolio, A. UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. J. Pharm. Biomed. Anal., 2017, 142, 279-285.
[http://dx.doi.org/10.1016/j.jpba.2017.05.018] [PMID: 28538203]
[http://dx.doi.org/10.1016/j.jpba.2017.05.018] [PMID: 28538203]
Article Metrics
8